Evolving Concepts in the Management of Newly Diagnosed Epithelial Ovarian Cancer

被引：21

作者：

Gourley, Charlie ^{[1
]}

Bookman, Michael A. ^{[2
]}

机构：

[1] Univ Edinburgh, Edinburgh, Midlothian, Scotland

[2] Kaiser Permanente Northern Calif, 2238 Geary Blvd 2E303, San Francisco, CA 94115 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 27期

关键词：

GRADE SEROUS OVARIAN; PHASE-III TRIAL; CARBOPLATIN PLUS PACLITAXEL; STAGE-III; PRIMARY PERITONEAL; ONCOLOGY-GROUP; 1ST-LINE TREATMENT; OPEN-LABEL; INTRAPERITONEAL CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY;

D O I：

10.1200/JCO.19.00337

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：2386 / +

页数：13

共 87 条

[1] OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [J].

Aghajanian, Carol ;

Blank, Stephanie V. ;

Goff, Barbara A. ;

Judson, Patricia L. ;

Teneriello, Michael G. ;

Husain, Amreen ;

Sovak, Mika A. ;

Yi, Jing ;

Nycum, Lawrence R. .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (17) :2039-2045

[2] Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer [J].

Alberts, DS ;

Liu, PY ;

Hannigan, EV ;

OToole, R ;

Williams, SD ;

Young, JA ;

Franklin, EW ;

ClarkePearson, DL ;

Malviya, VK ;

DuBeshter, B ;

Adelson, MD ;

Hoskins, WJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) :1950-1955

[3] Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes [J].

Alfaro, C. ;

Suarez, N. ;

Gonzalez, A. ;

Solano, S. ;

Erro, L. ;

Dubrot, J. ;

Palazon, A. ;

Hervas-Stubbs, S. ;

Gurpide, A. ;

Lopez-Picazo, J. M. ;

Grande-Pulido, E. ;

Melero, I. ;

Perez-Gracia, J. L. .

BRITISH JOURNAL OF CANCER, 2009, 100 (07) :1111-1119

[4]

[Anonymous], Surveillance, Epidemiology, and End Results Program, Cancer Stat Facts: Colorectal Cancer

[5] Bevacizumab-Induced Normalization of Blood Vessels in Tumors Hampers Antibody Uptake [J].

Arjaans, Marlous ;

Munnink, Thijs H. Oude ;

Oosting, Sjoukje F. ;

van Scheltinga, Anton G. T. Terwisscha ;

Gietema, Jourik A. ;

Garbacik, Erik T. ;

Timmer-Bosscha, Hetty ;

Lub-de Hooge, Marjolijn N. ;

Schroder, Carolina P. ;

de Vries, Elisabeth G. E. .

CANCER RESEARCH, 2013, 73 (11) :3347-3355

[6] Intraperitoneal cisplatin and paclitaxel in ovarian cancer [J].

Armstrong, DK ;

Bundy, B ;

Wenzel, L ;

Huang, HQ ;

Baergen, R ;

Lele, S ;

Copeland, LJ ;

Walker, JL ;

Burger, RA .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) :34-43

[7] Weekly paclitaxel in the treatment of recurrent ovarian cancer [J].

Baird, Richard D. ;

Tan, David S. P. ;

Kaye, Stan B. .

NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (10) :575-582

[8] A cell-based model exhibiting branching and anastomosis during tumor-induced angiogenesis [J].

Bauer, Amy L. ;

Jackson, Trachette L. ;

Jiang, Yi .

BIOPHYSICAL JOURNAL, 2007, 92 (09) :3105-3121

[9] Integrated genomic analyses of ovarian carcinoma [J].

Bell, D. ;

Berchuck, A. ;

Birrer, M. ;

Chien, J. ;

Cramer, D. W. ;

Dao, F. ;

Dhir, R. ;

DiSaia, P. ;

Gabra, H. ;

Glenn, P. ;

Godwin, A. K. ;

Gross, J. ;

Hartmann, L. ;

Huang, M. ;

Huntsman, D. G. ;

Iacocca, M. ;

Imielinski, M. ;

Kalloger, S. ;

Karlan, B. Y. ;

Levine, D. A. ;

Mills, G. B. ;

Morrison, C. ;

Mutch, D. ;

Olvera, N. ;

Orsulic, S. ;

Park, K. ;

Petrelli, N. ;

Rabeno, B. ;

Rader, J. S. ;

Sikic, B. I. ;

Smith-McCune, K. ;

Sood, A. K. ;

Bowtell, D. ;

Penny, R. ;

Testa, J. R. ;

Chang, K. ;

Dinh, H. H. ;

Drummond, J. A. ;

Fowler, G. ;

Gunaratne, P. ;

Hawes, A. C. ;

Kovar, C. L. ;

Lewis, L. R. ;

Morgan, M. B. ;

Newsham, I. F. ;

Santibanez, J. ;

Reid, J. G. ;

Trevino, L. R. ;

Wu, Y. -Q. ;

Wang, M. .

NATURE, 2011, 474 (7353) :609-615

[10] Hypoxia-induced down-regulation of BRCA1 expression by E2Fs [J].

Bindra, RS ;

Gibson, SL ;

Meng, A ;

Westermark, U ;

Jasin, M ;

Pierce, AJ ;

Bristow, RG ;

Classon, MK ;

Glazer, PM .

CANCER RESEARCH, 2005, 65 (24) :11597-11604

← 1 2 3 4 5 6 7 8 9 →